Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ubenimex - Eiger Biopharmaceuticals/Nippon Kayaku

Next Previous
X
Search
Drug Profile

Ubenimex - Eiger Biopharmaceuticals/Nippon Kayaku

Alternative Names: 1580RB; Bestatin; NK 421; Ubestatin

Latest Information Update: 09 Feb 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Institute of Microbial Chemistry
  • Developer Eiger BioPharmaceuticals, Inc.; Nippon Kayaku
  • Class Antineoplastics; Branched-chain amino acids; Dipeptides; Essential amino acids; Small molecules
  • Mechanism of Action Aminopeptidase B inhibitors; Aminopeptidase inhibitors; Immunostimulants; Leukotriene A4 hydrolase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Pulmonary arterial hypertension
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Acute nonlymphocytic leukaemia
  • Discontinued HIV infections; Inflammation; Lymphoedema; Pulmonary arterial hypertension

Most Recent Events

  • 09 Feb 2023 Discontinued - Preclinical for Inflammation in USA (PO)
  • 28 Dec 2019 No recent reports of development identified for preclinical development in Inflammation in USA (PO)
  • 28 Feb 2019 Eiger BioPharmaceuticals completes the ULTRA trial for Lymphoedema in Australia and USA (NCT02700529)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top